LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 1 of total 1

Search options

Article ; Online: Senotherapeutic drug treatment ameliorates chemotherapy-induced cachexia.

Englund, Davis A / Jolliffe, Alyssa M / Hanson, Gabriel J / Aversa, Zaira / Zhang, Xu / Jiang, Xinyi / White, Thomas A / Zhang, Lei / Monroe, David G / Robbins, Paul D / Niedernhofer, Laura J / Kamenecka, Theodore M / Khosla, Sundeep / LeBrasseur, Nathan K

JCI insight

2024  Volume 9, Issue 2

Abstract: Cachexia is a debilitating skeletal muscle wasting condition for which we currently lack effective treatments. In the context of cancer, certain chemotherapeutics cause DNA damage and cellular senescence. Senescent cells exhibit chronic activation of the ...

Abstract Cachexia is a debilitating skeletal muscle wasting condition for which we currently lack effective treatments. In the context of cancer, certain chemotherapeutics cause DNA damage and cellular senescence. Senescent cells exhibit chronic activation of the transcription factor NF-κB, a known mediator of the proinflammatory senescence-associated secretory phenotype (SASP) and skeletal muscle atrophy. Thus, targeting NF-κB represents a logical therapeutic strategy to alleviate unintended consequences of genotoxic drugs. Herein, we show that treatment with the IKK/NF-κB inhibitor SR12343 during a course of chemotherapy reduces markers of cellular senescence and the SASP in liver, skeletal muscle, and circulation and, correspondingly, attenuates features of skeletal muscle pathology. Lastly, we demonstrate that SR12343 mitigates chemotherapy-induced reductions in body weight, lean mass, fat mass, and muscle strength. These findings support senescent cells as a promising druggable target to counteract the SASP and skeletal muscle wasting in the context of chemotherapy.
MeSH term(s) Humans ; NF-kappa B/metabolism ; Signal Transduction ; Cachexia/chemically induced ; Cachexia/drug therapy ; Senotherapeutics ; Muscular Atrophy/chemically induced ; Muscular Atrophy/drug therapy ; Antineoplastic Agents/adverse effects
Chemical Substances NF-kappa B ; Senotherapeutics ; Antineoplastic Agents
Language English
Publishing date 2024-01-23
Publishing country United States
Document type Journal Article
ISSN 2379-3708
ISSN (online) 2379-3708
DOI 10.1172/jci.insight.169512
Database MEDical Literature Analysis and Retrieval System OnLINE

More links

Kategorien

To top